透過您的圖書館登入
IP:52.14.130.13
  • 學位論文

I.掌性1,3-二口咢環戊烷化合物之不對稱反應及天然物合成上之應用 II.開發高潛力組織蛋白酶S抑制劑

I. Application of Chiral 1,3-Dioxolan-4-ones in Asymmetric Reactions and Syntheses of Natural Products II. Discovery of Potent Inhibitors for Cathepsin S

指導教授 : 汪炳鈞
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


本論文研究包含兩個部份:第一部份是利用N,N-二異丙基-10-樟腦磺醯胺29作為掌性輔助基衍生之1,3-二口咢環戊-4-酮化合物36為起始物,進行奎寧酸前驅物65a的不對稱形式合成研究與LdT 96的不對稱形式合成研究;第二部份是以核心結構144為骨架來開發高潛力的組織蛋白酶S抑制劑。 I. (a) 在奎寧酸前驅物的不對稱形式合成研究方面:利用內酯縮酮化合物59為起始物衍生之化合物88與1,3-丁二烯進行不對稱Diels-Alder反應,得到乙醇酸衍生物69的前驅物93、94,合併總產率為39%,選擇性為4.9:1;或是利用內酯縮酮化合物36為起始物,進行不對稱的烷基化反應和ring-closing metathesis反應兩個關鍵步驟,共用了七步完成奎寧酸前驅物65a的合成,總產率33%。 (b) 在LdT的不對稱形式合成研究方面:利用內酯縮酮化合物36為起始物與alpha-三甲基矽烷丙烯醛131進行不對稱的醇醛反應,得到單一產物的1,2-相鄰雙醇130,共用了三步完成LdT前驅物123的合成,總產率37%。 II. 在開發高潛力的組織蛋白酶S抑制劑方面:修飾核心結構144上的苯環來合成一系列的144衍生物與合成alpha-酮醯胺衍生物179,可惜並未找到高潛力的組織蛋白酶S抑制劑。

並列摘要


This thesis consists of two parts. The first part was concerned with application of chiral 1,3-dioxolan-4-ones 36, derived from (1S)-(+)-N,N-diisopropyl-10-camphorsulfonamide 29, in enantioselective formal synthesis of precursor of (-)-quinic acid 65a and LdT 96. In the second part, discovering high potent Cathepsin S inhibitors based on skeleton of core structure 144 is described. I. (a) Enantioselective formal synthesis of precursor of (-)-quinic acid: Asymmetric Diel-Alder reaction of dienophile 88, derived from 1,3-dioxolan-4-ones 59, with 1,3-butadiene afforded precursors of glycolic acid 69 derivatives, 93, 94 in 39% yield. The diastereoselective ratio of Diel-Alder reaction is 4.9 : 1. On the other hand, A seven-step synthesis, including diastereoselective alkylation and ring-closing metathesis reactions, of precursor of (-)-quinic acid 65a from 1,3-dioxolan-4-ones 36 has been achieved in 33% overall yield. (b) Enantioselective formal synthesis of precursor of LdT: Aldol reaction of the enolate of 1,3-dioxolan-4-one 36 with alpha-trimethylsilyl acrolein 131 afforded corresponding product 130. A three-step synthesis of precursor of LdT 123 from aldol adduct 130 has been furnished in 37% overall yield. II. Discovery of potent Cathepsin S inhibitors: Synthesis of various core structure 144 derivatives and alpha-ketoamide 179 for inhibition of Cathepsin S. Unfortunately, those compounds has low IC50 value of Cathepsin S.

參考文獻


1.Calne, D. B.; Sandlar, M. Nature 1970, 226, 21.
2.“Reagents, Catalysts and Building Blocks for Enantioselective Synthesis Resolving Agent” Merck’s Chiralica.
3.Seyden-Penne J. In “Chiral Auxiliaries and Ligands in Asymmetric Synthesis”, John-Wiley and sons, New York, 1995.
15.(a) Seebach, D.; Naef, R.; Calderari, G. Tetrahedron, 1984, 40, 1313. (b) Seebach, D.; Renaud, P. Helv. Chim. Acta 1985, 68, 2342. (c) Grover, P. T. Bhongle, Nandkumar, N.; Wald, S. A.; Senanayake, C. H. J. Org. Chem. 2000, 65, 6283. (d) Nakamura, K. Baker, T. J.; Goodman, M. Org. Lett. 2000, 2, 2967. (e) Jiang, L.; Weist, S.; Jansat, S. Org. Lett. 2009, 11, 1543.
16.(a) Pearson, W. H.; Cheng, M. C. J. Org. Chem. 1986, 51, 3746. (b) Pearson, W. H.; Cheng, M. C. J. Org. Chem. 1987, 52, 3176. (c) Pearson, W. H.; Hines, J. V. J. Org. Chem. 1989, 54, 4235. (d) Chang, J.-W.; Jang, D.-P.; Uang, B.-J.; Liao, F.-L.; Wang, S.-L. Org. Lett. 1999, 1 2061. (e) Jang, D.-P.; Chang, J.-W.; Uang, B.-J. Org. Lett. 2001, 3, 983. (f) Paterson, L. Anderson, E. A.; Dalby, S. M. Lim, J. H.; Genovino, J.; Maltas, P.; Moessner, C. Angew. Chem. Int. Ed. 2008, 47, 3021.

延伸閱讀